U.S.A. v. Caronia
Dec 03, 2012OUTCOME: Defendant won. Conviction vacated.
This case redefines and expands First Amendment protection for commercial free speech. The Second Circuit held: "We conclude simply that the government cannot prosecute pharmaceutical manufacturers ... and their representatives under the FDCA for speech promoting the lawful, off-label use of an FDA-approved drug."
